pyrrolidin-3-yl-methanesulfonic acid has been researched along with Osteoporosis in 1 studies
*Osteoporosis: Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z; Ding, M; Kim, E; Kim, SK; Lee, S; Lee, TH; Park, SW; Rajamanickam, KR | 1 |
1 other study(ies) available for pyrrolidin-3-yl-methanesulfonic acid and Osteoporosis
| Article | Year |
|---|---|
Discovery of PMSA Derivative
Topics: Animals; Bone Resorption; Cell Differentiation; Humans; Mice; NFATC Transcription Factors; Osteoclasts; Osteogenesis; Osteoporosis; RANK Ligand; Transcription Factors | 2023 |